BACKGROUND: Previous research suggests that technology-enabled health care delivery may improve access to dermatologic specialty care. Outcomes research using validated outcomes measures is necessary for evaluation of novel health care delivery models. OBJECTIVE: We sought to compare the clinical equivalence of a novel patient-centered online health care delivery model with standard in-office care for follow-up treatment of patients with psoriasis. METHODS: A total of 64 participants with psoriasis were randomized to receive follow-up care either in-office or online over a 24-week period. Patients randomized to the online group underwent standardized training on capturing high-quality digital images of their psoriatic skin and transmitting these images and clinical history to a dermatologist securely. The dermatologist then performed asynchronous, online evaluation and provided recommendations directly to patients. We used clinically validated disease severity and quality-of-life measures to assess effectiveness between the models. RESULTS: Both online and in-office groups showed improvement in psoriasis disease severity as measured by mean improvement in Psoriasis Area and Severity Index (online group: mean = -3.4, in-office: mean = -3.4). Patient-centered online care resulted in similar improvement in psoriasis severity compared with in-person follow-up care (mean difference in Psoriasis Area and Severity Index change 0.1, 95% confidence interval -2.2 to 2.3, a priori equivalence margin of 2.5). Investigator Global Assessment and Dermatology Life Quality Index scores also improved during the study period; no significant differences existed between the two groups. LIMITATIONS: The follow-up period was limited to 24 weeks. CONCLUSION: A patient-centered online model may be an effective alternative to in-office care for follow-up management of psoriasis.
RCT Entities:
BACKGROUND: Previous research suggests that technology-enabled health care delivery may improve access to dermatologic specialty care. Outcomes research using validated outcomes measures is necessary for evaluation of novel health care delivery models. OBJECTIVE: We sought to compare the clinical equivalence of a novel patient-centered online health care delivery model with standard in-office care for follow-up treatment of patients with psoriasis. METHODS: A total of 64 participants with psoriasis were randomized to receive follow-up care either in-office or online over a 24-week period. Patients randomized to the online group underwent standardized training on capturing high-quality digital images of their psoriatic skin and transmitting these images and clinical history to a dermatologist securely. The dermatologist then performed asynchronous, online evaluation and provided recommendations directly to patients. We used clinically validated disease severity and quality-of-life measures to assess effectiveness between the models. RESULTS: Both online and in-office groups showed improvement in psoriasis disease severity as measured by mean improvement in Psoriasis Area and Severity Index (online group: mean = -3.4, in-office: mean = -3.4). Patient-centered online care resulted in similar improvement in psoriasis severity compared with in-person follow-up care (mean difference in Psoriasis Area and Severity Index change 0.1, 95% confidence interval -2.2 to 2.3, a priori equivalence margin of 2.5). Investigator Global Assessment and Dermatology Life Quality Index scores also improved during the study period; no significant differences existed between the two groups. LIMITATIONS: The follow-up period was limited to 24 weeks. CONCLUSION: A patient-centered online model may be an effective alternative to in-office care for follow-up management of psoriasis.
Authors: Elizabeth Krupinski; Gail Barker; Gilmer Rodriguez; Michael Engstrom; Norman Levine; Ana Maria Lopez; Ronald S Weinstein Journal: Telemed J E Health Date: 2002 Impact factor: 3.536
Authors: John D Whited; Russell P Hall; Marjorie E Foy; Laurie E Marbrey; Steven C Grambow; Tara K Dudley; Santanu K Datta; David L Simel; Eugene Z Oddone Journal: Telemed J E Health Date: 2004 Impact factor: 3.536
Authors: Abrar A Qureshi; Heather A Brandling-Bennett; Steven Giberti; Douglas McClure; Elkan F Halpern; Joseph C Kvedar Journal: J Telemed Telecare Date: 2006 Impact factor: 6.184
Authors: Joel M Gelfand; Shuwei Wang; Junko Takeshita; Andrew D Robertson; Gerald G Krueger; Kristina Callis Duffin; Abby S Van Voorhees Journal: JAMA Dermatol Date: 2013-04 Impact factor: 10.282
Authors: Lieneke Fm Ariens; Florine Ml Schussler-Raymakers; Cynthia Frima; Annebeth Flinterman; Eefje Hamminga; Bernd Wm Arents; Carla Afm Bruijnzeel-Koomen; Marjolein S de Bruin-Weller; Harmieke van Os-Medendorp Journal: J Med Internet Res Date: 2017-09-05 Impact factor: 5.428
Authors: April W Armstrong; Adam R Ford; Cindy J Chambers; Emanual Maverakis; Cory A Dunnick; Mary-Margaret Chren; Joel M Gelfand; Caitlin M Gibbons; Brittany M Gibbons; Christianne J Lane Journal: J Invest Dermatol Date: 2018-11-24 Impact factor: 8.551
Authors: April W Armstrong; Cindy J Chambers; Emanual Maverakis; Michelle Y Cheng; Cory A Dunnick; Mary-Margaret Chren; Joel M Gelfand; David J Wong; Brittany M Gibbons; Caitlin M Gibbons; Josefina Torres; Andrea C Steel; Elizabeth A Wang; Caitlin M Clark; Sanminder Singh; Heather A Kornmehl; Reason Wilken; Aleksandra G Florek; Adam R Ford; Chelsea Ma; Nazanin Ehsani-Chimeh; Sucharita Boddu; Mayumi Fujita; Paulina M Young; Cesar Rivas-Sanchez; Brenda I Cornejo; Laura C Serna; Eric R Carlson; Christianne J Lane Journal: JAMA Netw Open Date: 2018-10-05